Fresh Healthy Vending International Inc. (VEND) Financials

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Fresh Healthy Vending International Inc. (VEND) Financials Nov 14, 2014, 3:38 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Fresh Healthy Vending International Inc.


Fiscal year is July-June. All values USD millions. 2011 2012 2014 5-year trend
Sales/Revenue - - 0 0 5.26M
Cost of Goods Sold (COGS) incl. D&A - - 0 0 2.6M
COGS excluding D&A - - 0 0 2.54M
Depreciation & Amortization Expense - - 0 0 59,236
Depreciation - - 0 0 59,236
Amortization of Intangibles - - 0 0 0
Gross Income - - 0 0 2.66M
2011 2012 2014 5-year trend
SG&A Expense - - 1,634 55,836 5.04M
Research & Development - - 0 0 -
Other SG&A - - 1,634 55,836 5.04M
Other Operating Expense - - 0 0 0
Unusual Expense - - 0 0 -
EBIT after Unusual Expense - - 0 0 -
Non Operating Income/Expense - - 0 0 0
Non-Operating Interest Income - - - - 0
Equity in Affiliates (Pretax) - - 0 0 -
Interest Expense - - - 0 50,118
Gross Interest Expense - - - 0 50,118
Interest Capitalized - - 0 0 0
Pretax Income - - (1,634) (55,836) (2.43M)
Income Tax - - 0 0 2,400
Income Tax - Current Domestic - - 0 0 2,400
Income Tax - Current Foreign - - 0 0 -
Income Tax - Deferred Domestic - - 0 0 0
Income Tax - Deferred Foreign - - 0 0 -
Income Tax Credits - - 0 0 0
Equity in Affiliates - - 0 0 -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income - - (1,634) (55,836) (2.43M)
Minority Interest Expense - - 0 0 0
Net Income - - (1,634) (55,836) (2.43M)
Extraordinaries & Discontinued Operations - - 0 11,489 0
Extra Items & Gain/Loss Sale Of Assets - - 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - - 0 11,489 0
Net Income After Extraordinaries - - (1,634) (44,347) (2.43M)
Preferred Dividends - - 0 0 0
Net Income Available to Common - - (1,634) (55,836) (2.43M)
EPS (Basic) - - 0.00 () (0.10)
Basic Shares Outstanding - - 11.53M 16.22M 23.45M
EPS (Diluted) - - 0.00 () (0.10)
Diluted Shares Outstanding - - 11.53M 16.22M 23.45M
EBITDA - - (1,634) (55,836) (2.32M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading